Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. ALERTS, HOT STOCKS & CHARTS Message Board

SUGO SUGO SUGO R/M COMPLETION OF ACQUISITION O

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 145149
Posted On: 06/15/2015 8:17:28 AM
Avatar
Posted By: wayno2
SUGO SUGO SUGO R/M

COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.
Closing Of Share Exchange Agreement
On June 12, 2015, the Registrant, CaerVision Holdings, Inc., a Nevada corporation (“CaerVision”), consummated a Share Exchange with Amgentech, Inc. (“Amgentech”), a Florida corporation. Under the terms of the Share Exchange, the holders of AMGENTECH received 75,000,000 shares of CaerVision that had been previously issued to third parties in exchange for 100% of the issued and outstanding capital of AMGENTECH. A copy of the Share Exchange Agreement is attached hereto as Exhibit 2.01. It is the intention of management of CaerVision that this transaction be treated as a “reverse merger” with AMGENTECH treated as the successor issuer to CaerVision for SEC reporting and accounting purposes.

The Registrant has filed an Amendment to the Articles of Incorporation changing the name of the company to Telocuba, Inc.

ITEM 5.01

CHANGE IN CONTROL OF REGISTRANT

Under the terms of the Share Exchange detailed in Item 2.01, control of the Company was transferred to the previous shareholders of AMGENTECH and are held by William Sanchez, who now controls 80,000,000 shares of the Company’s common stock, representing approximately 60% of the total issued and outstanding common stock. Mr. Sanchez holds no additional shares of Registrant.


ITEM 5.02

CHANGE IN OFFICERS AND DIRECTORS

Under the terms of the Share Exchange detailed in Item 2.01, the shareholders of AMGENTECH were permitted to nominate representatives to serve on the Board of Directors to fill the seats vacated by prior directors. Accordingly, Erwin Vahlsing, Jr. resigned as an officer and director concurrent with the appointment of the following individuals to the Board of Directors and to serve in the capacities indicated until the next annual meeting of shareholders:

William Sanchez – Chairman; President; Secretary; Director

Mr. Sanchez has over 23 years of experience in the Internet and telecommunications space. He has been involved as a systems engineer and architect during the inception of various nascent companies, such as SportsLine (http://www.sportsline.com), StarMedia (http://www.starmedia.com), SportsAdvisors (http://www.sportsadvisors.com), DLJDirect, which is now http://www.e-trade.com, AMGTEL (http://www.amgtel.com) and Tribune Interactive (http://www.tribuneinteractive.com). His career has spanned many companies, but his commitment has always been the same. 95% of the companies he helped start are still active. His core has always been process automation and infrastructure. For the last 15 years, he has been president of Amgentech, Inc. (http://www.amgentech.com) - a full service technology solutions company. At Amgentech, Mr. Sanchez was retained to create the technical process and procedures as well as the internet components of well over 20 companies that are still viable.

Registrant has not executed employment contracts with any of the above-named individuals.

ITEM 8.01

OTHER EVENTS

Concurrent with the change in control, the Company has relocated its office and changed its phone number as follows:
New Address:

3440 NE 192nd Street, Suite 5F,

Aventura, Florida, 33180

New Phone:

(305) 747-7647

ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS

Registrant intends to file the audited financial statements of Amgentech, Inc. and pro-forma consolidated financial statements on Form 8-K 12(g) within 71 days of this filing.

Exhibit Number
Description
2.01 Share Exchange Agreement between CaerVision and Amgentech
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated June 15, 2015

CaerVision Global, Inc.

By: /s/ Erwin Vahlsing Jr.

Erwin Vahlsing Jr.

Chief Executive Officer



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us